Cardiovascular Systems, Inc.
CSII
CSII was delisted on the 27th of April, 2023.
2 hedge funds and large institutions have $1.37M invested in Cardiovascular Systems, Inc. in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 148 closing their positions.
99% less funds holding
Funds holding: 150 → 2 (-148)
100% less capital invested
Capital invested by funds: $767M → $1.37M (-$765M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 148
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$143M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$58.7M |
| 3 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
-$56.4M |
| 4 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$45.7M |
| 5 |
PCM
Pentwater Capital Management
Naples,
Florida
|
-$34.7M |
CSII Hedge Fund Activity: Q2 2023 in Review
2 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q2 2023, worth a combined $1.37M — down 100% from $767M a quarter earlier.
Sellers outnumbered buyers: 148 funds closed out of CSII and 0 opened new positions — a net loss of 148 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was BlackRock, exiting entirely with an estimated $143M sold.
- 2 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q2 2023, down from 150 in Q1 2023.
- Funds reported $1.37M of Cardiovascular Systems, Inc. stock for Q2 2023, down 100% quarter-over-quarter.
- 0 funds opened new Cardiovascular Systems, Inc. positions in Q2 2023 and 148 closed out, a net change of -148 holders.
- The largest Cardiovascular Systems, Inc. seller in Q2 2023 was BlackRock, an estimated $143M sold.
Based on aggregated 13F filings for Q2 2023.